Bafna Pharma IPO opens for subscription
The initial public offering of Bafna Pharmaceuticals opened for subscription Tuesday. The company is offering 64,00,000 equity shares of Rs 10 each for cash at premium of Rs 30 per share.
By ET Online |
MUMBAI: The initial public offering of Bafna Pharmaceuticals opened for subscription Tuesday. The company is offering 64,00,000 equity shares of Rs 10 each for cash at premium of Rs 30 per share. The issue to the public would constitute 40.05 per cent of the post issue paid-up capital. It closes on May 30.
Proceeds from the IPO would be utilized towards brand building in the domestic and international markets. Bafna would also strengthen its R&D facility at Grantlayon, besides getting MHRA certification. It also proposes to retire high-cost debts.
The shares are proposed to be listed on the BSE.
Proceeds from the IPO would be utilized towards brand building in the domestic and international markets. Bafna would also strengthen its R&D facility at Grantlayon, besides getting MHRA certification. It also proposes to retire high-cost debts.
The shares are proposed to be listed on the BSE.
Too busy to trade in stocks? Invest in Mutual Funds with ET Money!
Bookmark or read stories offline -
Download ET Markets APP
Download ET Markets APP
ADVERTISEMENT
